Hyponatremia during carbamazepine therapy in patients with intellectual disability

Journal of Intellectual Disability Research

Volumn 45, Issue 2, 2001, Pages 152-156

  Kelly, B D ^a   Hillery, J ^a  

^a Stewart's Hospital   (Ireland)

Author keywords

Adverse effects; Carbamazepine; Hyponatremia; Sodium

Indexed keywords

CARBAMAZEPINE; ELECTROLYTE; SODIUM;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MEGADOSE; ELECTROLYTE BLOOD LEVEL; FEMALE; GENDER; HUMAN; HYPONATREMIA; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MONITORING; POPULATION; PREVALENCE; RESIDENTIAL HOME; RETROSPECTIVE STUDY; RISK FACTOR; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARBAMAZEPINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPONATREMIA; MALE; MENTAL RETARDATION; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM;

EID: 0035052653     PISSN: 09642633     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2788.2001.00338.x     Document Type: Article

References (9)

1. Carbamazepine-induced hyponatremia in patients with mental retardation
2. Carbamazepine and serum sodium levels
3. Hyponatremia during carbamazepine therapy
4. Drug profiles IV: Carbamazepine and valproate
5. Hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs
6. Effects of carbamazepine on serum electrolytes: Clinical and theoretical implications
7. Carbamazepine and hyponatremia in patients with affective disorder